Previous studies have shown that circ-KLHL8 could be used as a candidate biomarker for the diagnosis of diabetes and promote epithelial healing, regulating endothelial cell apoptosis, survival, and maintaining endothelial function through activating the miR-212-3p/SIRT5 signaling pathway (27). Here, KLHL8 is linked to diabetes mellitus.